<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04648124</url>
  </required_header>
  <id_info>
    <org_study_id>ALR_2020_30</org_study_id>
    <nct_id>NCT04648124</nct_id>
  </id_info>
  <brief_title>VIsual Cerebral ConnecTivity On Functional Magnetic Resonance Imaging in Patients With Hereditary REtinal Dystrophies</brief_title>
  <acronym>VICTOIRE</acronym>
  <official_title>VIsual Cerebral ConnecTivity On Functional Magnetic Resonance Imaging in Patients With Hereditary REtinal Dystrophies</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fondation Ophtalmologique Adolphe de Rothschild</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fondation Ophtalmologique Adolphe de Rothschild</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Rothschild Foundation A Hospital follows a cohort of approximately 300 patients with&#xD;
      hereditary retinal dystrophy. These patients are followed in ophthalmology consultation every&#xD;
      year. In order to plan the MRI on the day of the annual consultation and to avoid additional&#xD;
      travel for patients, patients will be informed of the study before the consultation&#xD;
      (transmission of an information letter and the information note from study). If patients&#xD;
      agree to participate in the study, rMRI will be scheduled. During the follow-up&#xD;
      ophthalmologic consultation, after checking the inclusion and non-inclusion criteria, the&#xD;
      study information will be repeated, and patients who still agree to participate will sign the&#xD;
      study consent.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 4, 2021</start_date>
  <completion_date type="Anticipated">July 2026</completion_date>
  <primary_completion_date type="Anticipated">January 2024</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Localization and characterization of neural networks</measure>
    <time_frame>baseline</time_frame>
    <description>neuronal networks description using rest and morphological functionnal MRIs</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Evolution of neuronal networks after retinal implantation</measure>
    <time_frame>baseline</time_frame>
    <description>neuronal networks description using rest and morphological functionnal MRIs</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Vision Functional Brain Networks in Patients With Hereditary Retinal Dystrophies</condition>
  <arm_group>
    <arm_group_label>Patients for whom there is no planned implant surgery</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients for whom implantation surgery is planned</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>case</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>IRMf-r (séquence resting state)</intervention_name>
    <description>Functional MRI of functional brain networks</description>
    <arm_group_label>Patients for whom implantation surgery is planned</arm_group_label>
    <arm_group_label>Patients for whom there is no planned implant surgery</arm_group_label>
    <arm_group_label>case</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with hereditary retinal dystrophies whether or not to undergo implantation surgery&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient over 18 years old&#xD;
&#xD;
          -  Diagnostic clinique de dystrophie rétinienne héréditaire ou maculopathie héréditaire,&#xD;
             syndromique ou non syndromique&#xD;
&#xD;
          -  Artificial vision treatment such as a retinal implant, or optogenetics scheduled in&#xD;
             the next 6 months&#xD;
&#xD;
          -  Express consent to participate in the study&#xD;
&#xD;
          -  Affiliate or beneficiary of a social security scheme&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient benefiting from a legal protection measure&#xD;
&#xD;
          -  Pregnant or breastfeeding woman&#xD;
&#xD;
          -  Contraindication to MRI (claustrophobia, implanted equipment such as pacemaker).&#xD;
&#xD;
          -  Other additional ocular pathology that can significantly affect vision&#xD;
&#xD;
          -  Recent eye surgery less than 3 months old&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Augustin LECLER</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fondation Ophtalmologique A. de Rothschild</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Amélie YAVCHITZ</last_name>
    <phone>0148036454</phone>
    <email>ayavchitz@for.paris</email>
  </overall_contact>
  <location>
    <facility>
      <name>Fondation Adolphe de Rothschild</name>
      <address>
        <city>Paris</city>
        <zip>75019</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Augustin Lecler, PhD</last_name>
      <email>alecler@for.paris</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>August 26, 2020</study_first_submitted>
  <study_first_submitted_qc>November 27, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 1, 2020</study_first_posted>
  <last_update_submitted>July 15, 2021</last_update_submitted>
  <last_update_submitted_qc>July 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Retinal Dystrophies</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

